Ovid Therapeutics Inc. Human Resources Contracts & Agreements

26 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amended and Restated Executive Employment Agreement, dated September 9, 2024, between Ovid Therapeutics Inc. and Margaret Alexander
Employment Agreements
Ovid Therapeutics Inc.
Biotechnology
NY
2024
Non-Employee Director Compensation Policy, effective May 5, 2022
Compensation Agreements
Ovid Therapeutics Inc.
Biotechnology
2022
Non-Employee Director Compensation Policy, effective May 6, 2021
Compensation Agreements
Ovid Therapeutics Inc.
Biotechnology
2021
Amended and Restated Executive Employment Agreement between the Company and Jeffrey Rona, effective June 2, 2021
Employment Agreements
Ovid Therapeutics Inc.
Biotechnology
NY
2021
Amended and Restated Executive Employment Agreement between the Company and Thomas Perone, effective January 1, 2020
Employment Agreements
Ovid Therapeutics Inc.
Biotechnology
NY
2021
Executive Employment Agreement between the Company and Jason Tardio, effective October 21, 2019
Employment Agreements
Ovid Therapeutics Inc.
Biotechnology
NY
2021
Executive Employment Agreement between the Company and Jeff Rona, effective September 30, 2020
Employment Agreements
Ovid Therapeutics Inc.
Biotechnology
NY
2021
Third Amended and Restated Executive Employment Agreement between the Company and Tim Daly, effective December 18, 2019
Employment Agreements
Ovid Therapeutics Inc.
Biotechnology
NY
2020
Second Amended and Restated Executive Employment Agreement between the Company and Amit Rakhit, effective November 1, 2019
Employment Agreements
Ovid Therapeutics Inc.
Biotechnology
NY
2020
Non-Employee Director Compensation Plan
Compensation Agreements
Ovid Therapeutics Inc.
Biotechnology
2020
Separation and Consulting Agreement, by and between the Company and Matthew During, dated as of March 24, 2019
Consulting Agreements
Ovid Therapeutics Inc.
Biotechnology
2019
Amended and Restated Executive Employment Agreement between the Registrant and Yaron Werber
Employment Agreements
Ovid Therapeutics Inc.
Biotechnology
NY
2018
Amended and Restated Executive Employment Agreement between the Registrant and Matthew During
Employment Agreements
Ovid Therapeutics Inc.
Biotechnology
NY
2018
AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT
Employment Agreements
Ovid Therapeutics Inc.
Biotechnology
NY
2017
AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT
Employment Agreements
Ovid Therapeutics Inc.
Biotechnology
NY
2017
AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT
Employment Agreements
Ovid Therapeutics Inc.
Biotechnology
NY
2017
OVID THERAPEUTICS INC. STOCK OPTION GRANT NOTICE (2017 EQUITY INCENTIVE PLAN)
Bonus & Incentive Agreements
Ovid Therapeutics Inc.
Biotechnology
NY
2017
OVID THERAPEUTICS INC. 2017 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS: , 2017 APPROVED BYTHE STOCKHOLDERS: , 2017 IPODATE: , 2017
Bonus & Incentive Agreements
Ovid Therapeutics Inc.
Biotechnology
DE
2017
OVID THERAPEUTICS INC. 2014 EQUITY INCENTIVE PLAN STOCK OPTION AGREEMENT
Bonus & Incentive Agreements
Ovid Therapeutics Inc.
Biotechnology
NY
2017
OVID THERAPEUTICS INC. 2014 EQUITY INCENTIVE PLAN STOCK OPTION AGREEMENT EARLY EXERCISE
Bonus & Incentive Agreements
Ovid Therapeutics Inc.
Biotechnology
NY
2017
OVID THERAPEUTICS INC. 2014 EQUITY INCENTIVE PLAN RESTRICTED STOCK PURCHASE AGREEMENT
Bonus & Incentive Agreements
Ovid Therapeutics Inc.
Biotechnology
NY
2017
AMENDMENT TO OVID THERAPEUTICS INC. 2014 EQUITY INCENTIVE PLAN
Bonus & Incentive Agreements
Ovid Therapeutics Inc.
Biotechnology
2017
AMENDMENT TO OVID THERAPEUTICS INC. 2014 EQUITY INCENTIVE PLAN
Bonus & Incentive Agreements
Ovid Therapeutics Inc.
Biotechnology
2017
AMENDMENT TO OVID THERAPEUTICS INC. 2014 EQUITY INCENTIVE PLAN
Bonus & Incentive Agreements
Ovid Therapeutics Inc.
Biotechnology
2017
AMENDMENT TO OVIDTHERAPEUTICS INC. 2014 EQUITY INCENTIVE PLAN
Bonus & Incentive Agreements
Ovid Therapeutics Inc.
Biotechnology
2017
OVID THERAPEUTICS INC. 2014 EQUITY INCENTIVE PLAN
Bonus & Incentive Agreements
Ovid Therapeutics Inc.
Biotechnology
DE
2017